Metabolic interactions between immune cells and cardiomyocytes play a critical role in heart failure progression, highlighting potential targets for immunometabolic therapies.
Metabolic alterations are a hallmark of heart failure and differ across stages. The immune system plays a critical role in cardiac repair and injury during heart failure progression. Metabolic interactions between immune cells and cardiomyocytes are critical for influencing cellular states and cell-cell communications. Understanding these molecular intersections is essential to developing targeted therapies that regulate immunometabolism in the heart. In this review, we provide a comprehensive overview of the metabolic links between immune cells and cardiomyocytes during heart failure and discuss potential treatment strategies.
Erebholo et al. (Wed,) conducted a review in Heart failure. Metabolic interactions between immune cells and cardiomyocytes play a critical role in heart failure progression, highlighting potential targets for immunometabolic therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: